Share Email Print

Journal of Biomedical Optics • Open Access

Comparative evaluation of methylene blue and demeclocycline for enhancing optical contrast of gliomas in optical images
Author(s): Dennis J. Wirth; Matija Snuderl; William Curry; Anna Yaroslavsky

Paper Abstract

Contrast agents have shown to be useful in the detection of cancers. The goal of this study was to compare enhancement of brain cancer contrast using reflectance and fluorescence confocal imaging of two fluorophores, methylene blue (MB) and demeclocycline (DMN). MB absorbs light in the red spectral range and fluoresces in the near-infrared. It is safe for <italic<in vivo</italic< staining of human skin and breast tissue. However, its safety for staining human brain is questionable. Thus, DMN, which absorbs light in the violet spectral range and fluoresces between 470 and 570 nm, could provide a safer alternative to MB. Fresh human gliomas, obtained from surgeries, were cut in half and stained with aqueous solutions of MB and DMN, respectively. Stained tissues were imaged using multimodal confocal microscopy. Resulting reflectance and fluorescence optical images were compared with hematoxylin and eosin histopathology, processed from each imaged tissue. Results indicate that images of tissues stained with either stain exhibit comparable contrast and resolution of morphological detail. Further studies are required to establish the safety and efficacy of these contrast agents for use in human brain.

Paper Details

Date Published: 19 September 2014
PDF: 3 pages
J. Biomed. Opt. 19(9) 090504 doi: 10.1117/1.JBO.19.9.090504
Published in: Journal of Biomedical Optics Volume 19, Issue 9
Show Author Affiliations
Dennis J. Wirth, Univ. of Massachusetts Lowell (United States)
Matija Snuderl, NYU Langone Medical Ctr. and Medical School (United States)
William Curry, Massachusetts General Hospital (United States)
Anna Yaroslavsky, Univ. of Massachusetts Lowell (United States)

© SPIE. Terms of Use
Back to Top